The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Standards for Healthcare Service Design and Delivery in the UK for Adults and Children with Crohn’s Disease and Ulcerative Colitis: 2026 Update

  • By

  • Christopher A Lamb

  • Catherine Picton

  • Ian Arnott

  • Pearl Avery

  • Debra Attwood

  • Saswata Banerjee

  • Sarah Bayliss

  • Graham Bell

  • Gauraang Bhatnagar

  • Caroline Brocklehurst

  • Vicky Buckley

  • Valerio Celentano

  • Rachel Dodd

  • Amy Gittins

  • Katie Keetarut

  • Gayle Martin

  • Rafeeq Muhammed

  • Marianne Radcliffe

  • Fiona Rees

  • Ruth Rudling

  • Clare Tibbatts

  • Jessica Turner

  • Catherine Winsor

  • Nathaniel Woo

  • Lisa Younge

  • Christian P Selinger

  • IBD UK Board

  • A Barney Hawthorne

  • April 7, 2026

Share

Original Source(s)

The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis

  • by Christopher A Lamb, Catherine Picton, Ian Arnott, Pearl Avery, Debra Attwood, Saswata Banerjee, Sarah Bayliss, Graham Bell, Gauraang Bhatnagar, Caroline Brocklehurst, Vicky Buckley, Valerio Celentano, Rachel Dodd, Amy Gittins, Katie Keetarut, Gayle Martin, Rafeeq Muhammed, Marianne Radcliffe, Fiona Rees, Ruth Rudling, Clare Tibbatts, Jessica Turner, Catherine Winsor, Nathaniel Woo, Lisa Younge, Christian P Selinger, IBD UK Board, A Barney Hawthorne

  • April 7, 2026

Related Content

Ethosuximide vs Placebo for IBS Pain

Randomized trial found no improvement in abdominal pain and higher discontinuation rates with the calcium channel blocker.

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study

Escalating anti-tumour necrosis factor exposure with reductions in surgical resection rates in paediatric inflammatory bowel disease: an 18-year real-world population-based cohort study